Home214610 • KOSDAQ
add
MiCo BioMed Co Ltd
Previous close
â‚©1,430.00
Year range
â‚©1,132.00 - â‚©3,310.00
Market cap
63.28B KRW
Avg Volume
3.78M
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 2.48B | 76.25% |
Operating expense | 4.39B | 65.75% |
Net income | -6.13B | -20.83% |
Net profit margin | -247.56 | 31.44% |
Earnings per share | — | — |
EBITDA | -5.24B | -93.21% |
Effective tax rate | 0.05% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.32B | -21.40% |
Total assets | 38.27B | -14.92% |
Total liabilities | 20.82B | -50.09% |
Total equity | 17.45B | — |
Shares outstanding | 43.56M | — |
Price to book | 3.96 | — |
Return on assets | -35.63% | — |
Return on capital | -41.22% | — |
Cash Flow
Net change in cash
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -6.13B | -20.83% |
Cash from operations | -2.98B | -17.45% |
Cash from investing | -247.54M | 93.44% |
Cash from financing | 1.72B | -55.51% |
Net change in cash | -1.58B | 34.23% |
Free cash flow | -1.53B | 64.81% |
About
CEO
Founded
2009
Website
Employees
71